STOCK TITAN

Zomedica to Report Third Quarter 2024 Financial Results and Provide Business Update on November 7th at 4:30 p.m. ET

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

Zomedica (NYSE American:ZOM), a veterinary health company specializing in point-of-care diagnostic and therapeutic products for equine and companion animals, has scheduled its Q3 2024 earnings conference call for November 7, 2024, at 4:30 p.m. ET. The call will cover operational and financial highlights for the quarter ended September 30, 2024, followed by a Q&A session. Participants can join via phone (+1-800-717-1738 U.S. Toll-Free or +1-646-307-1865 International) or webcast. A replay will be available until November 21, 2024.

Zomedica (NYSE American:ZOM), un'azienda sanitaria veterinaria specializzata in prodotti diagnostici e terapeutici point-of-care per animali equini e da compagnia, ha programmato la sua conferenza telefonica sugli utili del Q3 2024 per il 7 novembre 2024, alle 16:30 ET. La chiamata discuterà i punti salienti operativi e finanziari del trimestre conclusosi il 30 settembre 2024, seguita da una sessione di domande e risposte. I partecipanti possono unirsi tramite telefono (+1-800-717-1738 numero verde USA o +1-646-307-1865 internazionale) oppure tramite webcast. Una registrazione sarà disponibile fino al 21 novembre 2024.

Zomedica (NYSE American:ZOM), una compañía de salud veterinaria especializada en productos diagnósticos y terapéuticos point-of-care para animales equinos y de compañía, ha programado su llamada de conferencia sobre ganancias del Q3 2024 para el 7 de noviembre de 2024, a las 4:30 p.m. ET. La llamada cubrirá los aspectos destacados operativos y financieros del trimestre que finalizó el 30 de septiembre de 2024, seguida de una sesión de preguntas y respuestas. Los participantes pueden unirse por teléfono (+1-800-717-1738 número gratuito en EE.UU. o +1-646-307-1865 internacional) o a través de la transmisión en vivo. Se dispondrá de una grabación hasta el 21 de noviembre de 2024.

조메디카 (NYSE American:ZOM)는 말과 반려동물을 위한 포인트 오브 케어 진단 및 치료 제품을 전문으로 하는 수의료 회사로, 2024년 3분기 실적 컨퍼런스 콜을 2024년 11월 7일 오후 4시 30분 ET에 예정하고 있습니다. 이 통화에서는 2024년 9월 30일로 종료된 분기의 운영 및 재무 하이라이트가 다뤄지며, 질문과 답변 세션이 이어집니다. 참가자는 전화(+1-800-717-1738 미국 무료 또는 +1-646-307-1865 국제) 또는 웹캐스트를 통해 참여할 수 있습니다. 녹음은 2024년 11월 21일까지 청취 가능합니다.

Zomedica (NYSE American:ZOM), une entreprise de santé vétérinaire spécialisée dans les produits de diagnostic et de traitement de point-of-care pour les équidés et les animaux de compagnie, a programmé sa conférence de résultats du T3 2024 pour le 7 novembre 2024 à 16h30 ET. L'appel couvrira les points saillants opérationnels et financiers pour le trimestre se terminant le 30 septembre 2024, suivi d'une session de questions-réponses. Les participants peuvent rejoindre par téléphone (+1-800-717-1738 numéro gratuit aux États-Unis ou +1-646-307-1865 international) ou par webdiffusion. Un enregistrement sera disponible jusqu'au 21 novembre 2024.

Zomedica (NYSE American:ZOM), ein Unternehmen der tiermedizinischen Gesundheitsbranche, das sich auf diagnostische und therapeutische Produkte für den Point-of-Care bei Pferden und Haustieren spezialisiert hat, hat seine Q3 2024 Ergebnis-Konferenzschaltung für den 7. November 2024 um 16:30 Uhr ET angesetzt. Der Anruf behandelt die operativen und finanziellen Höhepunkte des zum 30. September 2024 endenden Quartals, gefolgt von einer Frage- und Antwortsitzung. Die Teilnehmer können telefonisch (+1-800-717-1738 gebührenfrei in den USA oder +1-646-307-1865 international) oder per Webcast teilnehmen. Eine Wiederholung wird bis zum 21. November 2024 verfügbar sein.

Positive
  • None.
Negative
  • None.

ANN ARBOR, MI / ACCESSWIRE / October 23, 2024 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering point-of-care diagnostic and therapeutic products for equine and companion animals, will host a conference call and audio-only webcast on Thursday, November 7, 2024, at 4:30 p.m. ET to discuss the Company's operational and financial highlights for its thirdquarter ended September 30, 2024. A question-and-answer session will follow management's prepared remarks.

Event: Zomedica Corp. Q3 2024 Financial Results Conference Call

Date: Thursday, November 7, 2024

Time: 4:30 p.m. Eastern Time

Live Call: +1-800-717-1738 (U.S. Toll-Free) or +1-646-307-1865 (International)

Webcast: LINK

For interested individuals unable to join the conference call, a dial-in replay of the call will be available until Thursday, November 21, 2024 at 11:59 PM ET and can be accessed by dialing +1-844-512-2921 (U.S. Toll-Free) or +1-412-317-6671 (International) and entering replay pin number: 1120247

About Zomedica
Zomedica is a leading equine and companion animal healthcare company dedicated to improving animal health by providing veterinarians innovative therapeutic and diagnostic solutions. Our gold standard PulseVet® shock wave system, which accelerates healing in musculoskeletal conditions, has transformed veterinary therapeutics. Our suite of products also includes the Assisi® Loop line of therapeutic devices and the TRUFORMA® diagnostic platform, the TRUVIEW™ digital cytology system, and the VetGuardian® no-touch monitoring system, all designed to empower veterinarians to provide top-tier care. In the aggregate, their total addressable market in the U.S. exceeds $2 billion. Headquartered in Michigan, Zomedica employs approximately 150 people and manufactures and distributes its products from its world-class facilities in Georgia and Minnesota. An NYSE American company, Zomedica grew revenue 33% in 2023 to $25 million and maintains a strong balance sheet with approximately $83 million in liquidity as of June 30, 2024. Zomedica is advancing its product offerings, leveraging strategic acquisitions, and expanding internationally as we work to enhance the quality of care for pets, increase pet parent satisfaction, and improve the workflow, cash flow and profitability of veterinary practices. For more information visit www.zomedica.com.

Follow Zomedica

Email Alerts: http://investors.zomedica.com

LinkedIn: https://www.linkedin.com/company/zomedica

X (formerly Twitter): https://x.com/zomedica

Facebook: https://m.facebook.com/zomedica

Instagram: https://www.instagram.com/zomedica_inc

Investor Relations Contact:

Zomedica Investor Relations
investors@zomedica.com
1-734-369-2555

SOURCE: Zomedica Corp.



View the original press release on accesswire.com

FAQ

When will Zomedica (ZOM) report Q3 2024 earnings?

Zomedica will report its Q3 2024 earnings on Thursday, November 7, 2024, at 4:30 p.m. ET.

How can I listen to Zomedica's (ZOM) Q3 2024 earnings call?

You can join the call by dialing +1-800-717-1738 (U.S. Toll-Free) or +1-646-307-1865 (International), or via webcast.

Until when is Zomedica's (ZOM) Q3 2024 earnings call replay available?

The earnings call replay will be available until Thursday, November 21, 2024, at 11:59 PM ET.

Zomedica Corp.

NYSE:ZOM

ZOM Rankings

ZOM Latest News

ZOM Stock Data

128.18M
961.66M
1.78%
8.33%
5.12%
Medical Devices
Pharmaceutical Preparations
Link
United States of America
ANN ARBOR